Cell Counting Market
Number of pages: 100 | Report Format: PDF | Published date: June 14, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 8.25 billion |
|
Revenue Forecast in 2031 |
US$ 16.49 billion |
|
CAGR |
8% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global cell counting market was valued at US$ 8.25 billion in 2022 and is expected to register a revenue CAGR of 8% to reach US$ 16.49 billion by 2031.
Cell Counting Market Fundamentals
Cell counting refers to the process of determining the number of cells in a given sample or population. It is a fundamental technique used in various fields of biology and medicine to quantify cell populations for research, diagnostic, and experimental purposes. Cell counting can be performed manually using a microscope and a counting chamber, where cells are visually counted under magnification. This method is time-consuming and prone to human error but can be useful for certain applications. Alternatively, automated cell counting methods are widely used, especially when dealing with large numbers of cells. These methods utilize specialized instruments, such as flow cytometers or automated cell counters, which employ various techniques to count cells accurately and efficiently. Some common techniques include fluorescence-based detection, impedance-based counting, and image analysis. Cell counting is essential in numerous areas, including cell culture, medical diagnostics, immunology, cancer research, and drug development. It provides valuable information about cell viability, growth rates, cell cycle analysis, and cell-based assays, enabling researchers and clinicians to evaluate cellular responses, monitor diseases, and assess treatment efficacy.
Cell Counting Market Dynamics
The field of life sciences, including cell biology, genomics, drug discovery, and regenerative medicine, is continuously expanding. The rising demand for cell-based research and the need to understand cellular behavior and functions drive the cell counting market demand. Chronic diseases, including cancer, cardiovascular disorders, and autoimmune diseases, have risen significantly globally. Cell counting plays a crucial role in disease diagnosis, treatment monitoring, and drug development. The increasing prevalence of these diseases is fueling the cell counting market growth. According to the National Stem Cell Foundation, around 4% of the world’s population is affected by one of more than 80 different autoimmune diseases. The continuous development of advanced technologies and automated systems for cell counting has significantly improved the process's accuracy, speed, and efficiency. These technological advancements, such as flow cytometry, fluorescence-based detection, and image analysis, have increased the demand for cell counting solutions. The cell counting market outlook is positive as the biopharmaceutical industry is experiencing rapid growth, driven by biologics and personalized medicine development. Cell counting is essential in biopharmaceutical research, including cell line development, protein expression analysis, and cell-based assays. Stem cells hold tremendous potential in regenerative medicine, tissue engineering, and personalized therapies. Cell counting is crucial for isolating, expanding, and characterizing stem cells. The increasing focus on stem cell research and clinical applications creates a significant demand for cell counting technologies. The shift towards decentralized testing and point-of-care diagnostics has gained prominence. Cell counting technologies that offer portability, ease of use, and rapid results are in high demand for applications in remote areas, resource-limited settings, and emergency situations, which is also expected to boost the cell counting market growth.
However, advanced cell counting technologies, such as flow cytometers or automated cell counters, are costly to acquire and maintain. The high initial investment and ongoing expenses for equipment, reagents, and maintenance restrict cell counting market growth. Various sample contaminants, such as debris, cell clumps, or non-cellular particles, can interfere with accurate cell counting. These contaminants may lead to inaccurate cell counts or misidentification of cell populations, which is also expected to cramp the cell counting market growth.
Cell Counting Market Ecosystem
The global cell counting market is analyzed from four perspectives: product, application, end user, and region.
Cell Counting Market by Product
Based on the product, the global cell counting market is segmented into instruments and, consumables & accessories.
The consumables & accessories segment accounted for the largest cell counting market share in 2022, with a 60% market share. The consumables & accessories segment is further sub-segment into reagents, microplates, and others. Cell counting requires various consumables, including cell counting chambers, slides, reagents, disposable cuvettes, pipette tips, and stains. These consumables are used for sample preparation, loading, and analysis. Since these items are single-use or have limited usage, there is a continuous demand for their replenishment, leading to a consistent revenue stream for manufacturers. Consumables in cell counting are often used in large volumes due to the need to process multiple samples, conduct replicates, or analyze high cell numbers. Researchers and clinicians perform numerous cell counts daily, necessitating frequent replenishment of consumables. Consumables and accessories are typically designed to be compatible with various cell counting platforms, such as automated cell counters, flow cytometers, or image analysis systems. They serve as universal components that can be used across different instruments, increasing their market demand and utilization. Consumables and accessories generally have a lower price point than the high upfront cost of acquiring cell counting instruments. This makes them more accessible to a wide range of users, including small research laboratories, educational institutions, and clinical settings.
Cell Counting Market by Application
Based on the application, the global cell counting market is segmented into stem cell research, complete blood count, cell-based therapeutics, bioprocessing, toxicology, and others.
The complete blood count segment accounted for the prominent revenue share of the cell counting market, with a 53.6% market share. The complete blood count is a fundamental blood test routinely performed in clinical settings for assessing overall health and diagnosing various diseases and conditions. It provides essential information about different types of blood cells, including red blood cells, white blood cells, and platelets, along with parameters such as cell count, size, and hemoglobin levels. Complete blood count results aid in diagnosing and monitoring conditions such as anemia, infections, leukemia, and immune disorders, making it an integral part of medical practice. According to the WHO, 40% of children aged 6 to 59 months, 37% of pregnant women, and 30% of women aged 15 to 49 are anemic worldwide. The complete blood count is one of the most commonly ordered blood tests, with a significant volume of tests conducted daily worldwide. It is performed in hospitals, clinics, laboratories, and point-of-care settings, contributing to the consistently high demand for complete blood count analysis. Complete blood count analysis has undergone significant automation in recent years. Automated hematology analyzers are widely used for complete blood count testing, offering rapid and accurate results. These analyzers employ advanced cell counting technologies, including impedance-based, fluorescence-based, or flow cytometry-based methods, to analyze blood cells.
Cell Counting Market by End User
Based on the end users, the global cell counting market is segmented into hospitals, diagnostic laboratories, research & academic institutes, biotechnology companies, and others.
The research & academic institutes segment accounted for the highest cell counting market share in 2022, with a 33% market share. Research and academic institutes play a critical role in advancing scientific knowledge and conducting various types of research. Cell counting is an essential technique used in numerous research areas, including cell biology, immunology, cancer research, stem cell research, drug discovery, and regenerative medicine. Research and academic institutes often receive substantial funding from government agencies, private foundations, and academic institutions to support research projects and laboratory infrastructure. This funding enables these institutes to invest in advanced cell counting technologies, instruments, and consumables, driving the growth of this segment in the market. Research institutes are involved in large-scale research projects that require high-throughput cell counting and analysis. These projects may involve screening large libraries of compounds, conducting high-content analyses, or studying complex cellular interactions.
Cell Counting Market by Region
The global cell counting market has been geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The North America region has the largest cell counting market size in revenue generation, accounting for around 34.2% market share. North America is home to a significant number of research institutes, academic institutions, and pharmaceutical companies engaged in extensive research and development activities. The region strongly focuses on advancing scientific knowledge, developing innovative therapies, and conducting clinical trials. The growing research and development initiatives drive the demand for cell counting technologies and solutions to support these activities. North America has a high burden of chronic diseases such as cancer, cardiovascular diseases, and autoimmune disorders. Cell counting plays a crucial role in diagnosing and monitoring these conditions and evaluating treatments’ efficacy. According to the American Autoimmune Related Diseases Association (AARDA), up to 50 million Americans are thought to have an autoimmune disease with an annual economic impact of $86 billion. North America places a strong emphasis on personalized medicine and precision diagnostics. Cell counting technologies are integral to these approaches, as they enable the characterization of individual patient samples, identification of biomarkers, and assessment of treatment response. There is a growing demand for point-of-care testing in North America, driven by the need for immediate and accessible diagnostic results. Portable and user-friendly cell counting devices that can be used at the point of care enable faster decision-making, improved patient management, and reduced healthcare costs. The demand for point-of-care cell counting solutions is driving innovation in the region.
Cell Counting Market Competitive Landscape
The prominent players operating in the global cell countingmarket are:
Cell Counting Market Strategic Developments
Cell counting refers to the process of determining the number of cells in a given sample or population. It is a fundamental technique used in various fields of biology and medicine to quantify cell populations for research, diagnostic, and experimental purposes.
Asia Pacific can be considered the key growth region due to the surge in cell counting industry trends in China, Japan, and the Indian subcontinent.
The prominent players operating in the global cell counting market are Thermo Fisher Scientific, Inc., Becton, Dickinson and Company (BD), Merck KGaA, PerkinElmer, Inc., and Danaher.
The global cell counting market growth is estimated to grow at a revenue CAGR of 8% during the forecast period from 2023 to 2031.
The estimated size of the global cell counting market in 2031 is US$ 16.49 billion.
*Insights on financial performance are subject to the availability of information in the public domain